DEVELOPMENT OF A CHEMOKINE TARGETED THERAPY FOR INCLUSION BODY MYOSITIS

Awardee: Steven Greenberg

Institution: Brigham and Women's Hospital

Award Amount: $102,430

Previous
Previous

Attention-deficit and hyperactivity links to the brain connectivity of MPS I subjects: multimodal MRI study

Next
Next

Defining the cellular site of action of the Glut1 protein in Glucose Transporter 1 deficiency syndrome.